Takeda Pharmaceutical Management
Management criteria checks 4/4
Takeda Pharmaceutical's CEO is Christophe Weber, appointed in Jun 2014, has a tenure of 9.83 years. total yearly compensation is ¥1.72B, comprised of 17.1% salary and 82.9% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth $16.26M. The average tenure of the management team and the board of directors is 9.5 years and 6.5 years respectively.
Key information
Christophe Weber
Chief executive officer
JP¥1.7b
Total compensation
CEO salary percentage | 17.1% |
CEO tenure | 9.8yrs |
CEO ownership | 0.04% |
Management average tenure | 9.5yrs |
Board average tenure | 6.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | JP¥178b |
Sep 30 2023 | n/a | n/a | JP¥192b |
Jun 30 2023 | n/a | n/a | JP¥301b |
Mar 31 2023 | JP¥2b | JP¥295m | JP¥317b |
Dec 31 2022 | n/a | n/a | JP¥275b |
Sep 30 2022 | n/a | n/a | JP¥213b |
Jun 30 2022 | n/a | n/a | JP¥197b |
Mar 31 2022 | JP¥2b | JP¥281m | JP¥230b |
Dec 31 2021 | n/a | n/a | JP¥439b |
Sep 30 2021 | n/a | n/a | JP¥473b |
Jun 30 2021 | n/a | n/a | JP¥431b |
Mar 31 2021 | JP¥2b | JP¥267m | JP¥376b |
Dec 31 2020 | n/a | n/a | JP¥181b |
Sep 30 2020 | n/a | n/a | JP¥56b |
Jun 30 2020 | n/a | n/a | JP¥120b |
Mar 31 2020 | JP¥2b | JP¥273m | JP¥44b |
Dec 31 2019 | n/a | n/a | JP¥13b |
Sep 30 2019 | n/a | n/a | JP¥83b |
Jun 30 2019 | n/a | n/a | JP¥64b |
Mar 31 2019 | JP¥2b | JP¥269m | JP¥135b |
Dec 31 2018 | n/a | n/a | JP¥110b |
Sep 30 2018 | n/a | n/a | JP¥141b |
Jun 30 2018 | n/a | n/a | JP¥120b |
Mar 31 2018 | JP¥1b | JP¥254m | JP¥187b |
Compensation vs Market: Christophe's total compensation ($USD10.91M) is about average for companies of similar size in the US market ($USD13.53M).
Compensation vs Earnings: Christophe's compensation has been consistent with company performance over the past year.
CEO
Christophe Weber (57 yo)
9.8yrs
Tenure
JP¥1,723,000,000
Compensation
Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 9.8yrs | JP¥1.72b | 0.040% ¥ 16.3m | |
President of Research & Development and Representative Director | no data | JP¥972.00m | 0.0035% ¥ 1.4m | |
Chair of Management Board | no data | no data | no data | |
Chief Financial Officer | no data | no data | no data | |
Member of Management Board | no data | no data | no data | |
Member of Management Board and Head of R&D Global Science & Biomedical Policy | no data | no data | no data | |
Chief Accounting Officer & Corporate Controller | no data | no data | no data | |
Senior Vice President of Corporate Finance & Controlling Department | 11.1yrs | no data | no data | |
Chief Data & Technology Officer | 2.2yrs | no data | no data | |
Global Head of Investor Relations & Global Finance | 3.6yrs | no data | no data | |
Global General Counsel | 9.5yrs | no data | no data | |
Chief Ethics & Compliance Officer | 9.5yrs | no data | no data |
9.5yrs
Average Tenure
55yo
Average Age
Experienced Management: TKPH.F's management team is seasoned and experienced (9.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 9.8yrs | JP¥1.72b | 0.040% ¥ 16.3m | |
President of Research & Development and Representative Director | 8.8yrs | JP¥972.00m | 0.0035% ¥ 1.4m | |
Independent External Director | 5.3yrs | JP¥38.00m | 0.00026% ¥ 105.6k | |
Independent External Director | 7.8yrs | JP¥43.00m | no data | |
Independent External Director | 7.8yrs | JP¥41.00m | 0.00057% ¥ 231.6k | |
Independent External Director | 5.3yrs | JP¥38.00m | 0.000070% ¥ 28.4k | |
Independent External Director | 4.8yrs | JP¥38.00m | no data | |
Independent External Director | 5.3yrs | JP¥38.00m | 0.000040% ¥ 16.3k | |
Independent External Director | 7.8yrs | JP¥39.00m | no data | |
Independent External Chair | 2.8yrs | JP¥43.00m | no data | |
Independent External Director | 7.8yrs | JP¥43.00m | 0.00041% ¥ 166.6k | |
Representative Director | 4.8yrs | JP¥690.00m | no data |
6.5yrs
Average Tenure
65.5yo
Average Age
Experienced Board: TKPH.F's board of directors are considered experienced (6.5 years average tenure).